A recent report published by Infinium Global Research on enzyme-linked immunosorbent assay (ELISA) testing market provides in-depth analysis of segments and sub-segments in the global as well as regional enzyme-linked immunosorbent assay (ELISA) testing market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional enzyme-linked immunosorbent assay (ELISA) testing market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global enzyme-linked immunosorbent assay (ELISA) testing market. According to the report, the global enzyme-linked immunosorbent assay (ELISA) testing market is projected to grow at a healthy CAGR over the forecast period of 2019-2025.
Enzyme-linked immunosorbent assay (ELISA) testing market has been around as one of the crucial methods of analytic detection for more than four decades. Several changes to the basic format have resulted in assay improvements over the years, however some of the most recent look set to take the traditional ELISA to new levels. These innovations include numerous vendors now addressing the automation of ELISA assays. Some automated platforms include novel or alternative ELISA formats typically with reduced or microfluidic components. Other automated instrumentation is intended to support the coating of ELISA assay plates or contains cartridge-based delivery of assay reagents to decrease set-up time. Innovative developments in automated plate washing and the minimization of wash steps are also impacting conventional ELISAs.
The increasing incidences of cancer across the globe is the major driving factor for the enzyme-linked immunosorbent assay (ELISA) testing market. ELISA testing is mainly used to measure antibodies, antigens, proteins, and glycoproteins in biological samples. Furthermore, factors such as the growing need for frequent testing among the aging population, budding government support, mounting occurrence of target diseases are other driving factors for the market. The increasing number of cases of infectious diseases are boosting the growth of the market. However, the lack of accessibility and affordability of diagnostic tests are expected to restrain the growth of the market. Moreover, continuous development of the innovative and novel product by players in markets coupled with the launch of these products is anticipated to provide growth opportunities to the market players.
Geographically, North America dominates the global enzyme-linked immunosorbent assay (ELISA) testing market owing to the increasing prevalence of chronic disease and improved healthcare infrastructure in this region. Asia-Pacific is the fastest-growing region in the market, due to the large population base, increasing prevalence of chronic diseases, and technological advancements. In addition, increasing healthcare expenditure and developing healthcare infrastructure are supporting the growth of the market in the Asia-Pacific region.
The report on global enzyme-linked immunosorbent assay (ELISA) testing market covers segments such as test types and applications. On the basis of test types, the sub-markets include sandwich ELISA, indirect ELISA, multiple and portable ELISA, and competitive ELISA. On the basis of applications, the sub-markets include immunology, inflammation, infectious diseases, cancer, protein quantitation, and other applications.
The report provides profiles of the companies in the market such as Thermo Fisher Scientific. Inc., Ortho Clinical Diagnostics Inc., Life Technologies Corporation, ZEUS Scientific, Inc., Abcam, bioMérieux, BD, Bio-Rad Laboratories, Thermo Fisher Scientific, Agilent Technologies Inc., and other companies.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of enzyme-linked immunosorbent assay (ELISA) testing market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter